Search

Author/Creator Van Zyl, Louis

1. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Issue 10184 (11th May 2019)

Authors:
Heerspink, Hiddo J L; Parving, Hans-Henrik; Andress, Dennis L; Bakris, George; Correa-Rotter, Ricardo; Hou, Fan-Fan; Kitzman, Dalane W; Kohan, Donald; Makino, Hirofumi; McMurray, John J V; Melnick, Joel Z; Miller, Michael G; Pergola, Pablo E; Perkovic, Vlado; Tobe, Sheldon; Yi, Tingting; Wigderso...
Journal:
Lancet
Issue:
Volume 393:Issue 10184(2019)
Page Start:
1937
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial. Issue 8 (August 2022)

Authors:
Cools, Frank; Virdone, Saverio; Sawhney, Jitendra; Lopes, Renato D; Jacobson, Barry; Arcelus, Juan I; Hobbs, F D Richard; Gibbs, Harry; Himmelreich, Jelle C L; MacCallum, Peter; Schellong, Sebastian; Haas, Sylvia; Turpie, Alexander G G; Ageno, Walter; Rocha, Ana Thereza; Kayani, Gloria; Pieper, K...
Journal:
Lancet
Issue:
Volume 9:Issue 8(2022)
Page Start:
e594
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search